Prof. Harats MD is a professor of medicine in the department of biochemistry at the Sackler Faculty of Medicine, Tel-Aviv University, Israel. He is the senior VP of Research and Development and the Chairman of the IRB committee at the Sheba Medical Centre, Tel-Hashomer, Israel

Prof. Harats is a graduate of the Hadassah Medical School at the Hebrew University, Jerusalem. He completed his residency in Internal Medicine at Hadassah and fellowship in Pulmonary and molecular biology at the University of California, San Francisco (UCSF). For the past 25 years Prof. Harats has been involved in "cutting edge" Research in Lipid Metabolism, Atherosclerosis and Vascular Biology. He was one of the pioneers who discovered the role of the immune system in atherosclerosis and invented a new genetic tool for the treatment of angiogenesis, a process that plays a major role in cancer and cardiovascular disorders. Prof. Harats is an entrepreneur who founded few biopharmaceutical companies focused on the discovery, development of first in class treatments in an unmet need. His research was published in more than 212 papers and chapters in books and rewarded him with numerous prizes and grants in the field of atherosclerosis and cancer.